Earkart Limited
Earkart Manufacture and distribute modern hearing aids and related accessories at affordable price across India. Along with our own manufactured hearing aid, we also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad.(Source : 202509 Prospectus Page No: 20)
- Market Cap ₹ 218 Cr.
- Current Price ₹ 158
- High / Low ₹ 266 / 136
- Stock P/E 40.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 45.1 %
- ROE 41.8 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.3%
Cons
- Company has high debtors of 159 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE SME IPO
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 5.66 | 28.42 | 30.80 | 42.75 | |
| 5.52 | 26.79 | 27.22 | 32.96 | |
| Operating Profit | 0.14 | 1.63 | 3.58 | 9.79 |
| OPM % | 2.47% | 5.74% | 11.62% | 22.90% |
| 0.04 | 0.05 | 0.21 | 0.09 | |
| Interest | 0.01 | 0.08 | 0.36 | 0.44 |
| Depreciation | 0.06 | 0.15 | 0.19 | 0.42 |
| Profit before tax | 0.11 | 1.45 | 3.24 | 9.02 |
| Tax % | 0.00% | 9.66% | 5.86% | 23.61% |
| 0.11 | 1.31 | 3.06 | 6.88 | |
| EPS in Rs | 22.00 | 262.00 | 612.00 | 6.59 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 96% |
| TTM: | 39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 297% |
| TTM: | 125% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 35% |
| Last Year: | 42% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 0.05 | 10.44 | 13.75 |
| Reserves | 4.72 | 6.49 | 12.97 | 9.48 | 52.31 |
| 0.27 | 1.23 | 4.02 | 4.96 | 5.62 | |
| 0.91 | 6.96 | 2.21 | 5.41 | 6.50 | |
| Total Liabilities | 5.95 | 14.73 | 19.25 | 30.29 | 78.18 |
| 0.22 | 0.25 | 1.06 | 1.17 | 1.61 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.46 | 0.10 | 0.19 | 0.83 | 0.83 |
| 4.27 | 14.38 | 18.00 | 28.29 | 75.74 | |
| Total Assets | 5.95 | 14.73 | 19.25 | 30.29 | 78.18 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -2.83 | -0.30 | -1.00 | 0.71 | |
| -1.78 | 0.40 | -1.29 | -1.32 | |
| 4.68 | 0.41 | 3.08 | -0.41 | |
| Net Cash Flow | 0.07 | 0.51 | 0.80 | -1.01 |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 104.47 | 60.36 | 75.13 | 158.55 |
| Inventory Days | 138.26 | 100.90 | 113.12 | 95.52 |
| Days Payable | 92.17 | 107.33 | 19.28 | 44.04 |
| Cash Conversion Cycle | 150.56 | 53.93 | 168.97 | 210.03 |
| Working Capital Days | 192.17 | 61.90 | 111.40 | 140.19 |
| ROCE % | 23.89% | 29.02% | 45.13% |
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting
18 Dec - Board authorised Independent Director to review valuation and due diligence for acquiring Turtle Maarks LLP; next meeting 23 Dec 2025.
-
Board Meeting Intimation for Prior Intimation For A Board Meeting To Be Held On 18Th December'' 2025
15 Dec - Board meeting 18 Dec 2025 to consider investment to acquire Turtle Maarks LLP.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9 Dec - Transcript of Earnings Call held on 9th December'' 2025
-
Submission Of Audio Recording Of Earnings Call.
4 Dec - Audio recording of Dec 4, 2025 earnings call (H1 FY26) available online; MD and CFO attended.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
27 Nov - Earnings Call is scheduled to be held on Thursday, December 4 2025 at 4:00 P.M. (IST)
Annual reports
No data available.
Concalls
-
Dec 2025Transcript PPT
Business Profile[1]
Earkart manufactures and distributes modern hearing aids (BTE & RIC) and accessories, trades third-party hearing aids and parts, and also supplies mobility aids (foldable walkers) and educational/therapy kits (MSIED and TLM) for children with disabilities.